Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHELLE DARLIN MAURINA

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Gerontology

NPI
1174172803
CMS profile
10770358
Location
SHIRLEY, NY

General Payments · PY2021–2024

$1,654.70

  • Reported across 59 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$835.67

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $750.68 35
Education $84.99 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $262.08 12
Novo Nordisk AS $197.71 10
Astellas Pharma US Inc $141.59 3
Lilly USA, LLC $87.55 4
GENZYME CORPORATION $56.08 2
ALK-Abello, Inc $29.32 2
Bioventus LLC $23.54 1
PFIZER INC. $21.06 1
Janssen Pharmaceuticals, Inc $16.74 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $106.76 1
PY2022 $190.53 4
PY2023 $521.74 18
PY2024 $835.67 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ALK-Abello, Inc $15.88 07/12/2024 Food and Beverage Undisputed 01/23/2026 1099893087 CMS
ALK-Abello, Inc $13.44 07/27/2024 Food and Beverage Undisputed 01/23/2026 1099893085 CMS
Astellas Pharma US Inc $27.60 01/18/2024 Food and Beverage Undisputed 01/23/2026 1139468346 CMS
Astellas Pharma US Inc $84.99 02/28/2024 Education Undisputed 01/23/2026 1139504277 CMS
Astellas Pharma US Inc $29.00 05/21/2024 Food and Beverage Undisputed 01/23/2026 1139509705 CMS
AstraZeneca Pharmaceuticals LP $16.87 01/30/2024 Food and Beverage Undisputed 01/23/2026 1104585642 CMS
AstraZeneca Pharmaceuticals LP $16.36 02/06/2024 Food and Beverage Undisputed 01/23/2026 1105629554 CMS
AstraZeneca Pharmaceuticals LP $14.45 03/25/2024 Food and Beverage Undisputed 01/23/2026 1104267053 CMS
AstraZeneca Pharmaceuticals LP $18.83 04/02/2024 Food and Beverage Undisputed 01/23/2026 1105232607 CMS
AstraZeneca Pharmaceuticals LP $14.29 04/04/2024 Food and Beverage Undisputed 01/23/2026 1105399134 CMS
AstraZeneca Pharmaceuticals LP $24.15 05/16/2024 Food and Beverage Undisputed 01/23/2026 1105897892 CMS
AstraZeneca Pharmaceuticals LP $64.31 06/27/2024 Food and Beverage Undisputed 01/23/2026 1105758981 CMS
AstraZeneca Pharmaceuticals LP $11.37 07/09/2024 Food and Beverage Undisputed 01/23/2026 1105590322 CMS
AstraZeneca Pharmaceuticals LP $18.55 08/29/2024 Food and Beverage Undisputed 01/23/2026 1104494124 CMS
AstraZeneca Pharmaceuticals LP $20.78 09/10/2024 Food and Beverage Undisputed 01/23/2026 1105901798 CMS
AstraZeneca Pharmaceuticals LP $24.14 10/17/2024 Food and Beverage Undisputed 01/23/2026 1104544176 CMS
AstraZeneca Pharmaceuticals LP $17.98 11/14/2024 Food and Beverage Undisputed 01/23/2026 1105590184 CMS
Bioventus LLC $23.54 02/15/2024 Food and Beverage Undisputed 01/23/2026 1137455954 CMS
GENZYME CORPORATION $28.67 09/12/2024 Food and Beverage Undisputed 01/23/2026 1139676411 CMS
GENZYME CORPORATION $27.41 10/29/2024 Food and Beverage Undisputed 01/23/2026 1139676437 CMS
Janssen Pharmaceuticals, Inc $16.74 09/17/2024 Food and Beverage Undisputed 01/23/2026 1078118856 CMS
Lilly USA, LLC $20.47 04/03/2024 Food and Beverage Undisputed 01/23/2026 1135758882 CMS
Lilly USA, LLC $18.36 04/08/2024 Food and Beverage Undisputed 01/23/2026 1135746888 CMS
Lilly USA, LLC $30.26 05/28/2024 Food and Beverage Undisputed 01/23/2026 1135758884 CMS
Lilly USA, LLC $18.46 07/23/2024 Food and Beverage Undisputed 01/23/2026 1135758886 CMS
Novo Nordisk Inc $19.10 01/16/2024 Food and Beverage Undisputed 01/23/2026 1100373126 CMS
Novo Nordisk Inc $22.05 03/12/2024 Food and Beverage Undisputed 01/23/2026 1100266338 CMS
Novo Nordisk Inc $18.19 03/26/2024 Food and Beverage Undisputed 01/23/2026 1100524193 CMS
Novo Nordisk Inc $18.78 04/23/2024 Food and Beverage Undisputed 01/23/2026 1100567222 CMS
Novo Nordisk Inc $18.21 05/14/2024 Food and Beverage Undisputed 01/23/2026 1100490521 CMS
Novo Nordisk Inc $25.00 06/11/2024 Food and Beverage Undisputed 01/23/2026 1100443113 CMS
Novo Nordisk Inc $18.71 07/16/2024 Food and Beverage Undisputed 01/23/2026 1100643459 CMS
Novo Nordisk Inc $18.47 09/25/2024 Food and Beverage Undisputed 01/23/2026 1100509343 CMS
Novo Nordisk Inc $15.15 10/08/2024 Food and Beverage Undisputed 01/23/2026 1100280058 CMS
Novo Nordisk Inc $24.05 11/12/2024 Food and Beverage Undisputed 01/23/2026 1100548010 CMS
PFIZER INC. $21.06 06/04/2024 Food and Beverage Undisputed 01/23/2026 1131900103 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.